Some studies have summarized that the in vitro data of adiponectin’s antitumor proliferation effect in breast cancer are mainly limited to full-length adiponectin (fAd) (105, 106), one of the forms of adiponectin. The gene discussed is ADIPOQ; the disease is breast carcinoma.